← Leaderboards
Stephen H Parker
Synageva Biopharma Corporation
$91,727
Attributed
$91,727
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$91,727 · 1
By mechanism
R43$91,727 · 1
Top collaborators
No co-investigators on record.
Most similar at Synageva Biopharma Corporation
Same institution · by research overlap
- Mark C. Leavitt$1,556,851
- Alex Jordan Harvey$1,714,526
- Leandro Christmann$623,937
Others in their field
Top investigators on “Antiantibody”
- Robert S Zeiger · University Of California San Diego$3,508,018
- Opendra Narayan · University Of Kansas Medical Center$2,886,995
- Toshiaki Kawakami · La Jolla Inst For Allergy &Immunolgy$1,924,634
- Todd E. Golde · Mayo Clinic Coll Of Med, Jacksonville$1,697,005
- Wadih Arap · Rutgers Biomedical And Health Sciences$1,692,155
- Claudio Anasetti · Fred Hutchinson Cancer Research Center$1,488,450
Research focus
AntiantibodyBioreactorsBiotechnologyBiotherapeutic AgentCd40 MoleculeCell LineComplementary DnaEgg Food ProductEnzyme Linked Immunosorbent AssayGenetically Modified AnimalsImmunoglobulin GImmunologic Substance Development /PreparationLysozymeMicroinjectionsMonoclonal AntibodyQuailTechnology /Technique DevelopmentTransfection